Luca Alberici, Ph.D., Chief Business Officer
Milan, Italy
MolMed is a biotechnology company focused on research, development, production, and clinical validation of gene and cell therapies for the treatment of cancer and rare diseases. Thanks to the experience and know-how acquired in over 20 years of activity, MolMed is a reference player in the cell and gene sector, able to manage all phases of research up to the commercialization of advanced gene and cell therapies. Thanks to its authorized facilities, MolMed offers GMP development and production services for gene and cell therapies, providing resources and experience in carrying out studies from the preclinical phase to marketing.

By using this website you agree to accept our Privacy Policy and Terms & Conditions